CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Cash and Cash Equivalents
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Cash and Cash Equivalents of $192.03 million as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-05
- 2026-06-27: Cash and Cash Equivalents, at Carrying Value $192.03M.
- 2026-03-28: Cash and Cash Equivalents, at Carrying Value $191.83M.
- 2025-12-27: Cash and Cash Equivalents, at Carrying Value $213.77M.
- 2025-09-27: Cash and Cash Equivalents, at Carrying Value $207.10M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-27 | $192.03M 10-Q · filed 2026-08-05 | |
| 2026-03-28 | $191.83M 10-Q · filed 2026-05-07 | |
| 2025-12-27 | $213.77M 10-Q · filed 2026-08-05 | |
| 2025-09-27 | $207.10M 10-Q · filed 2025-11-05 | |
| 2025-06-28 | $182.82M 10-Q · filed 2026-08-05 | |
| 2025-03-29 | $229.36M 10-Q · filed 2026-05-07 | |
| 2024-12-28 | $194.61M 10-K · filed 2026-02-18 | |
| 2024-09-28 | $210.17M 10-Q · filed 2025-11-05 | |
| 2024-06-29 | $179.21M 10-Q · filed 2025-08-06 | |
| 2024-03-30 | $327.04M 10-Q · filed 2025-05-07 | |
| 2023-12-30 | $276.77M 10-K · filed 2025-02-19 | |
| 2023-09-30 | $157.17M 10-Q · filed 2024-11-06 | |
| 2023-07-01 | $200.44M 10-Q · filed 2023-08-09 | |
| 2023-04-01 | $201.59M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $233.91M 10-K · filed 2024-02-14 | |
| 2022-09-24 | $193.70M 10-Q · filed 2022-11-02 | |
| 2022-06-25 | $200.32M 10-Q · filed 2022-08-03 | |
| 2022-03-26 | $241.87M 10-Q · filed 2023-05-11 | |
| 2021-12-25 | $241.21M 10-K · filed 2023-02-22 | |
| 2021-09-25 | $212.54M 10-Q · filed 2022-11-02 | |
| 2021-06-26 | $222.97M 10-Q · filed 2022-08-03 | |
| 2021-03-27 | $465.41M 10-Q · filed 2022-05-04 | |
| 2020-12-26 | $228.42M 10-K · filed 2023-02-22 | |
| 2020-09-26 | $242.88M 10-Q · filed 2021-11-03 | |
| 2020-06-27 | $402.02M 10-Q · filed 2021-08-04 | |
| 2020-03-28 | $372.43M 10-Q · filed 2021-05-04 | |
| 2019-12-28 | $238.01M 10-K · filed 2022-02-16 | |
| 2019-09-28 | $164.76M 10-Q · filed 2020-10-29 | |
| 2019-06-29 | $200.59M 10-Q · filed 2020-08-05 | |
| 2019-03-30 | $126.32M 10-Q · filed 2020-05-07 | |
| 2018-12-29 | $195.44M 10-K · filed 2021-02-17 | |
| 2018-09-29 | $138.87M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $192.30M 10-Q · filed 2019-07-31 | |
| 2018-03-31 | $187.77M 10-Q · filed 2019-05-07 | |
| 2017-12-30 | $163.79M 10-K · filed 2020-02-11 | |
| 2017-09-30 | $123.62M 10-Q · filed 2018-11-07 | |
| 2017-07-01 | $116.47M 10-Q · filed 2018-08-08 | |
| 2017-04-01 | $131.52M 10-Q · filed 2018-05-10 | |
| 2016-12-31 | $117.63M 10-K · filed 2019-02-13 | |
| 2016-09-24 | $105.72M 10-Q · filed 2017-11-09 | |
| 2016-06-25 | $154.59M 10-Q · filed 2017-08-09 | |
| 2016-03-26 | $157.38M 10-Q · filed 2017-05-10 | |
| 2015-12-26 | $117.95M 10-K · filed 2018-02-13 | |
| 2015-09-26 | $74.03M 10-Q · filed 2016-11-02 | |
| 2015-06-27 | $150.81M 10-Q · filed 2016-08-03 | |
| 2015-03-28 | $151.92M 10-Q · filed 2016-05-04 | |
| 2014-12-27 | $160.02M 10-K · filed 2017-02-14 | |
| 2014-09-27 | $130.75M 10-Q · filed 2015-11-04 | |
| 2014-06-28 | $117.01M 10-Q · filed 2015-07-30 | |
| 2014-03-29 | $169.85M 10-Q · filed 2015-04-30 | |
| 2013-12-28 | $155.93M 10-K · filed 2017-02-14 | |
| 2013-09-28 | $130.45M 10-Q · filed 2014-10-30 | |
| 2013-06-29 | $113.52M 10-Q · filed 2014-08-07 | |
| 2013-03-30 | $100.42M 10-Q · filed 2014-04-30 | |
| 2012-12-29 | $109.69M 10-K · filed 2016-02-12 | |
| 2012-09-29 | $83.22M 10-Q · filed 2013-10-30 | |
| 2012-06-30 | $76.08M 10-Q · filed 2013-07-31 | |
| 2012-03-31 | $61.03M 10-Q · filed 2013-05-08 | |
| 2011-12-31 | $68.91M 10-K · filed 2015-02-17 | |
| 2011-09-24 | $81.22M 10-Q · filed 2011-11-02 | |
| 2011-06-25 | $81.22M 10-Q · filed 2012-11-01 | $145.83M 10-Q · filed 2011-08-03 |
| 2011-03-26 | $158.75M 10-Q · filed 2012-05-04 | |
| 2010-12-25 | $179.16M 10-K · filed 2014-02-25 | |
| 2010-09-25 | $137.43M 10-Q · filed 2011-11-02 | |
| 2010-06-26 | $219.08M 10-Q · filed 2011-08-03 | |
| 2010-03-27 | $222.20M 10-Q · filed 2011-05-04 | |
| 2009-12-26 | $182.57M 10-K · filed 2013-02-27 | |
| 2009-09-26 | $192.20M 10-Q · filed 2010-11-04 | |
| 2009-06-27 | $154.81M 10-Q · filed 2010-08-03 | |
| 2008-12-27 | $243.59M 10-K · filed 2012-02-27 | |
| 2007-12-29 | $225.45M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |